Odontologic Universitary Clinic
Murcia, 30008, Spain
NCT Number: NCT03142828
The work hyposesis is based on the application of a chlorhexidine gel against the non-application on the healing abutments in patients who have received a submerged titanium implant to check its effect on healing and prevention of bacterial plaque accumulation during a period of 1 month.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Murcia, 30008, Spain
Once the implants are integrated, and given the consent, the patients will be operated to connect the healing abutments as they come from the manufacturer (Mozo Grau, Ticare®). Patients will follow the study protocol in 2 arms.
The random distribution is made prior to assignment following the internet program https://www.random.org
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Healing abutment with Clorhexidine
Other names: CHX
Healing abutment without any antiseptic
Time frame: 1 month after second surgery
Degree of inflammation was measured using a 4-point Likert scaleInflammation 0 = non-inflamed gingiva with pale pink color. Inflammation 1 = erythematous gingiva without bleeding on manipulation. Inflammation 2 = gingiva with slight bleeding during manipulation during unscrewing or screwing of the abutment. Inflammation 3 = gingiva with heavy bleeding during manipulation during unscrewing or screwing of the abutment.
Universidad de Murcia
Other
Effect of the Application of Chlorhexidine in the Pillars of Implant Healing to Prevent Plate Accumulation. Controlled Random Blind Clinical Study.
Acronym: CHX-HA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06849856
Mouth Diseases, Peri-Implantitis
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07379892
Mouth Diseases, Peri-Implantitis
Aydin, Turkey (Türkiye)
View Trial DetailsNCT06695559
Mouth Diseases, Peri-Implantitis
Thessaloniki, Greece
View Trial DetailsNCT05811390
Mouth Diseases, Peri-Implantitis
Porto, Porto District, Portugal
View Trial Details